DK114340B - Fremgangsmåde til fremstilling af terapeutisk virksomme gona-4,9-dien-3-oner eller de tilsvarende D-homoforbindelser. - Google Patents

Fremgangsmåde til fremstilling af terapeutisk virksomme gona-4,9-dien-3-oner eller de tilsvarende D-homoforbindelser.

Info

Publication number
DK114340B
DK114340B DK228063AA DK228063A DK114340B DK 114340 B DK114340 B DK 114340B DK 228063A A DK228063A A DK 228063AA DK 228063 A DK228063 A DK 228063A DK 114340 B DK114340 B DK 114340B
Authority
DK
Denmark
Prior art keywords
gona
dien
ones
preparation
therapeutically effective
Prior art date
Application number
DK228063AA
Other languages
English (en)
Inventor
D Hartley
G Hughes
H Smith
Original Assignee
H Smith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Smith filed Critical H Smith
Publication of DK114340B publication Critical patent/DK114340B/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Transmission Devices (AREA)
  • Pyridine Compounds (AREA)
DK228063AA 1962-05-15 1963-05-14 Fremgangsmåde til fremstilling af terapeutisk virksomme gona-4,9-dien-3-oner eller de tilsvarende D-homoforbindelser. DK114340B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19497262A 1962-05-15 1962-05-15

Publications (1)

Publication Number Publication Date
DK114340B true DK114340B (da) 1969-06-23

Family

ID=22719572

Family Applications (2)

Application Number Title Priority Date Filing Date
DK228063AA DK114340B (da) 1962-05-15 1963-05-14 Fremgangsmåde til fremstilling af terapeutisk virksomme gona-4,9-dien-3-oner eller de tilsvarende D-homoforbindelser.
DK228263AA DK116056B (da) 1962-05-15 1963-05-14 Fremgangsmåde til fremstilling af 13-alkyl-gona-4,9-dien-3-oner eller deres D-homo-analoge.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK228263AA DK116056B (da) 1962-05-15 1963-05-14 Fremgangsmåde til fremstilling af 13-alkyl-gona-4,9-dien-3-oner eller deres D-homo-analoge.

Country Status (13)

Country Link
US (1) US3502699A (da)
JP (1) JPS4812737B1 (da)
AT (2) AT283609B (da)
BR (1) BR6349095D0 (da)
CH (1) CH494213A (da)
DE (3) DE1793633C3 (da)
DK (2) DK114340B (da)
ES (2) ES288360A1 (da)
FI (1) FI41741B (da)
FR (1) FR3896M (da)
IT (1) IT1061776B (da)
NO (2) NO124598B (da)
SE (5) SE323668B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723533A (en) * 1968-02-27 1973-03-27 American Cyanamid Co Substituted naphthalenone and naphthalenedione compounds
JPS5320840Y2 (da) * 1973-11-21 1978-06-01
DE2718872A1 (de) * 1976-06-14 1977-12-22 Jenapharm Veb Verfahren zur herstellung von neuen gona-4,9(10)-dienen
FR2618783B1 (fr) * 1987-07-30 1991-02-01 Roussel Uclaf Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant
US9982009B2 (en) 2013-10-15 2018-05-29 Massachusetts Institute Of Technology Methods for treating polycystic kidney disease and polycystic liver disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3069421A (en) * 1961-04-12 1962-12-18 Roussel Uclaf Process for the preparation of delta5(10)-estrene-17beta-ol-3-one and intermediates

Also Published As

Publication number Publication date
AT272532B (de) 1969-07-10
DE1618973B2 (de) 1973-10-31
CH494213A (de) 1970-07-31
AT283609B (de) 1970-08-10
DE1618973C3 (de) 1974-06-06
SE330164B (da) 1970-11-09
DE1618973A1 (de) 1971-12-30
BR6349095D0 (pt) 1973-08-02
DE1793633C3 (de) 1973-10-04
DK116056B (da) 1969-12-08
NO124597B (da) 1972-05-08
SE323669B (da) 1970-05-11
SE323668B (da) 1970-05-11
SE330165B (da) 1970-11-09
NO124598B (da) 1972-05-08
ES288360A1 (es) 1963-12-01
ES288359A1 (es) 1963-12-01
DE1793633B2 (de) 1973-03-08
FI41741B (da) 1969-10-31
US3502699A (en) 1970-03-24
IT1061776B (it) 1983-04-30
SE330166B (da) 1970-11-09
FR3896M (da) 1966-02-07
DE1468642B1 (de) 1971-03-11
JPS4812737B1 (da) 1973-04-23
DE1793633A1 (de) 1971-12-30

Similar Documents

Publication Publication Date Title
DK115403B (da) Fremgangsmåde til fremstilling af (3-amino-pyrazinoyl)-guanidiner.
DK118655B (da) Analogifremgangsmåde til fremstilling af p-aminoalkoxyphenylalkenderivater.
DK104675C (da) Fremgangsmåde til fremstilling af 3-hydroxy-N-nitro-picolinamid.
DK113999B (da) Fremgangsmåde til fremstilling af β-aminoacylphenyl-forbindelser.
DK122319B (da) Fremgangsmåde til fremstilling af L-α-methyl-3,4-dihydroxyphenylalanin.
DK114340B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme gona-4,9-dien-3-oner eller de tilsvarende D-homoforbindelser.
DK115325B (da) Fremgangsmåde til fremstilling af fenylalkylsulfamider.
DK105471C (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepin-3H-forbindelser.
DK111447B (da) Fremgangsmåde til fremstilling af 17α-vinyl-5(10)-østren-17β-ol-3-on.
DK103476C (da) Fremgangsmåde til fremstilling af 2-oxa-3-oxo-steroider.
DK109199C (da) Fremgangsmåde til fremstilling af 19-nor-steroidforbindelser.
DK124261B (da) Analogifremgangsmåde til fremstilling af tertiære carbamyltriazoler.
DK131114B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 17alfa-halogenalkynylgona-4,9-dien-3-oner eller de tilsvarende D-homo-forbindelser.
DK108915C (da) Fremgangsmåde til fremstilling af 21-acyloxy-acetyloxy-corticosteroider.
DK103512C (da) Fremgangsmåde til fremstilling af 3-nitroso-2-oxazolidon.
DK104303C (da) Fremgangsmåde til fremstilling af 3α-hydroxy-11-oxo-21,21-bis-(hydroxymethyl)-5β-pregnan eller estere deraf.
DK132031B (da) Analogifremgangsmåde til fremstilling af 17-haloalkynyl-17-hydroxy-13-ethyl-gonen-3-oner eller de tilsvarende D-homo-forbindelser.
DK104063C (da) Fremgangsmåde til fremstilling af 4-hydroxy-5-halogenpyrimidiner.
DK115620B (da) Fremgangsmåde til fremstilling af 17α-klorætynyl-17βalkoksysteroider.
DK113647B (da) Fremgangsmåde til fremstilling af 2-sulfanilamido-5-metoxypyrimidin.
DK103081C (da) Fremgangsmåde til fremstilling af 2,6-diketo-8-thiapuriner.
DK115852B (da) Fremgangsmåde til fremstilling af 2,4-diamino-6-hydroxymethyl-7,8-dihydropteridin.
DK109324C (da) Fremgangsmåde til fremstilling af 1-brom-chlor-2,2-difluorpropan.
DK106091C (da) Fremgangsmåde til fremstilling af 17α-alkyl-17β-hydroxy-2-azaandrostan-3-oner eller 17α-alkyl-17β-hydroxy-3-aza-A-homoandrostan-4-oner.
DK101860C (da) Fremgangsmåde til fremstilling af 1-formylcolchiciner eller -thiocolchiciner.